Josh Resnick
Signal active
Co-Founder & General Partner
Bio
Josh Resnick is the Co-Founder and General Partner of Pure Imagination Brands. He is a former Co-Founder and CEO of Sugarfina. He attended Wharton School of the University of Pennsylvania.
Location
Los Angeles, California, United States, North America
Social
Primary Organization
Pure Imagination Brands
Founded
2019
Investment
51
Lead investment
0
Exits
4
Employees
1-10
Industry
Financial Services, Finance, Business Development
Jobs history
5
Triana Biomedicines
Board Member
Invalid date - Current
Pure Imagination Brands
Co-Founder & General Partner
2019 - Current
Avilar Therapeutics
Board Member
2021 - Current
Neuro
Advisor
2018 - Current
Bright Peak Therapeutics
Board Member
2021 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Josh Resnick is the Co-Founder & General Partner at Pure Imagination Brands, based in United States, North America. With a background in Financial Services, Josh Resnick has a rich history of leadership and innovation. Josh Resnick studied MBA unknown @ Wharton School of the University of Pennsylvania. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
Josh Resnick has made 6 investments. Their Latest investment was Convertible Note - Upwage on Apr 12, 2022
Number of investment
6
Number of exits
0
Personal investment
6
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Sep 12, 2011 | Playdek | Seed Round - Playdek | 655.0K |
| Jan 01, 2019 | Honeybee Health | Pre Seed Round - Honeybee Health | 0 |
| Jan 05, 2021 | Uprising Food | Series A - Uprising Food | 1.3M |
| Apr 12, 2022 | Upwage | Convertible Note - Upwage | 2.0M |
PlaydekPartner investment
6
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Nov 18, 2021 | Avilar Therapeutics | Seed Round - Avilar Therapeutics | RA Capital Management | 60.0M |
| Dec 01, 2021 | Mariana Oncology | Series A - Mariana Oncology | RA Capital Management | 75.0M |
| Sep 07, 2023 | Mariana Oncology | Series B - Mariana Oncology | RA Capital Management | 175.0M |
| Jun 11, 2024 | Bright Peak Therapeutics | Series C - Bright Peak Therapeutics | RA Capital Management | 90.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.